MSB - Mesoblast bone repair trial 'highly successful' 1/1

AAP General News (Australia)
02-13-2008
MSB - Mesoblast bone repair trial 'highly successful' 1/1
MSB - Company Announcement
$gen0
13 February 2008
Part 1/1
--------

Mesoblast bone repair trial 'highly successful'

Sydney - Wednesday - Feb 13: (RWE Australian Business News) -
Mesoblast Ltd (ASX:MSB) today announced "highly successful" results from
its clinical trial at The Royal Melbourne Hospital in 10 patients
suffering from non-healing, long bone fractures of the legs.

All 10 patients have been followed up for at least six months
post-implantation with stem cells produced using Mesoblast's proprietary
technology. No adverse events related to Mesoblast's cells occurred.

All patients have shown new bone formation. Seven achieved union
of their long bone defects within a median period of 4.9 months, and
three continue to show progressive new bone formation.

In contrast, none of the 10 had shown any evidence of new bone
formation for five to 41 months before stem cell implantation.

ENDS

KEYWORD: COMNEWS MSB SYDNEY 1001/1/1

2008 AAP Information Services Pty Limited (AAP) or its Licensors.